Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Ganirelix for luteolysis in poor responder patients undergoing IVF treatment: a Scandinavian multicenter 'extended pilot study'

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Differentiated timing of induction for women with intrahepatic cholestasis of pregnancy - a historical cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Length of hospital stay after cesarean section in Denmark from 2004 to 2016: a national register-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Female cigarette smoking and successful fertility treatment: a Danish cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pregnancy loss. A 40-year nationwide assessment

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Proteome of fluid from human ovarian small antral follicles reveals insights in folliculogenesis and oocyte maturation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Serum ferritin level is inversely related to number of previous pregnancy losses in women with recurrent pregnancy loss

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. N-acetylcysteine protects ovarian follicles from ischemia-reperfusion injury in xenotransplanted human ovarian tissue

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Umbilical cord blood-derived platelet-rich plasma: a clinically acceptable substitute for fetal bovine serum?

    Research output: Contribution to journalEditorialResearchpeer-review

View graph of relations
To enhance oocyte yield and pregnancy outcome in poor responder women undergoing IVF treatment, daily low dose GnRH antagonist administration was given during the late luteal phase to induce luteolysis and possibly secure a more synchronous cohort of recruitable follicles. An open extended pilot study in four Scandinavian fertility centers was done including 60 patients. Poor response was defined as when <or = 5 follicles developed in a preceding cycle following a long agonist protocol with the use of > 2000 IU FSH. GnRH antagonist (ganirelix) was given, 0.25 mg s.c. daily, from days 3 to 5 before expected start of menstruation and continued for 4-7 days. On cycle day 2-3 a starting dose of rFSH (300-400 IU/day) was given. At a leading follicle diameter of 14 mm, ganirelix administration was resumed until final oocyte maturation was induced with 10,000 IU hCG. GnRH antagonist only marginally affected the intercycle FSH rise; basal levels of FSH remained similar to those seen after 4 days of antagonist administration. The protocol effectively induced low LH levels and luteolysis, but daily administration of 350 IU rFSH (median) for 11 days only led to the collection of 3 oocytes in 49 oocyte retrievals resulting in 5 pregnancies (4 delivered). Despite GnRH antagonist administration in the late luteal phase and menstrual bleeding, FSH was not sufficiently reduced to secure a more synchronic cohort of recruitable follicles. Novel GnRH antagonists more specifically targeting FSH release may improve the stimulation results in poor responders.
Original languageEnglish
JournalActa Obstetricia et Gynecologica Scandinavica
Volume89
Issue number6
Pages (from-to)828-31
Number of pages4
ISSN0001-6349
DOIs
Publication statusPublished - 2010

ID: 32169914